PeerView Oncology

 

Genitourinary
13:00

PeerView Oncology

2020 Updates in Advanced RCC: What Are the New SoC Options for Favorable and Poor/Intermediate Risk Patients? Is CTLA-4 Blockade Synergistic With Anti-PD-1?

FEATURING Hans Hammers
  • 445 views
  • November 27, 2020
  • 4
10:20

PeerView Oncology

Targeting DNA Repair Defects Through PARPi in mPC: Why Are Somatic/Germline Alterations Important? How Can We Selectively Stop BRCA-Mutated Disease? Do BRCA 2 Carriers Have Worse Prognosis? What Are the Current NCCN Testing Guidelines?

FEATURING Emmanuel Antonarakis
  • 220 views
  • November 16, 2020